FSKAX vs VT: 58% overlap
Fidelity Total Market Index and Vanguard Total World Stock ETF share 58.1% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 4 months apart — FSKAX as of 2026-02-28, the rest through 2026-06-30. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.4. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
FSKAX and VT hold 1,470 of the same securities. The ten contributing most to the overlap figure:
| Holding | in FSKAX | in VT | Δ |
|---|---|---|---|
| NVDA | 6.5% | 4.0% | 2.4% |
| AAPL | 5.9% | 3.6% | 2.3% |
| MSFT | 4.4% | 2.4% | 2.0% |
| AMZN | 3.1% | 2.0% | 1.1% |
| GOOGL | 2.7% | 1.8% | 0.9% |
| AVGO | 2.3% | 1.5% | 0.8% |
| GOOG | 2.2% | 1.4% | 0.7% |
| META | 2.1% | 1.1% | 1.1% |
| TSLA | 1.7% | 1.1% | 0.6% |
| LLY | 1.3% | 0.8% | 0.4% |
Where FSKAX and VT differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | FSKAX | VT | Δ |
|---|---|---|---|
| Communication Services | 9.7% | 7.0% | +2.7pp |
| Financials | 12.2% | 14.9% | −2.7pp |
| Health Care | 9.8% | 7.7% | +2.1pp |
| Industrials | 9.6% | 11.5% | −1.8pp |
| Materials | 1.8% | 3.3% | −1.5pp |
| Consumer Discretionary | 9.6% | 8.6% | +1.0pp |
| Consumer Staples | 5.1% | 4.6% | +0.5pp |
| Energy | 3.5% | 3.0% | +0.4pp |
Δ is FSKAX minus VT, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
5.3% of FSKAX by weight, held in no part of VT.
38.9% of VT by weight, held in no part of FSKAX.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| FSKAX | VT | |
|---|---|---|
| Top 10 holdings | 32.1% | 20.5% |
| Positions held | 3,754 | 9,600 |
| Cost per $10,000 held, per year | $1 | $6 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do FSKAX and VT overlap?
FSKAX and VT overlap 58.1% by portfolio weight — substantial duplication if you hold both. They share 1,470 holdings. The figure comes from current issuer holdings files (FSKAX as of 2026-02-28, VT as of 2026-06-30).
How is the overlap between FSKAX and VT calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If FSKAX holds a stock at 6% and VT holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both FSKAX and VT?
That depends on your goals — we state facts, not advice. At 58.1% overlap, each fund still contributes meaningfully distinct exposure.
What does FSKAX own that VT doesn't?
FSKAX holds 3,754 positions and VT holds 9,600; 2,283 of FSKAX's positions don't appear in VT at all, and they are 5.3% of FSKAX by weight.
You probably hold more than two funds
This page compares FSKAX and VT. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch FSKAX vs VT
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, FSKAX as of 2026-02-28, VT as of 2026-06-30. Weights are fractions of each fund. Diagnostics, not advice.